Clinical Trials

35 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05935098 2026-03-13

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

99 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT04900818 2026-03-05

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

330 enrolled

Adenocarcinoma Of Esophagus, Biliary Tract Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT06226571 2026-02-17

A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

Other hematologic neoplasm

76 enrolled

Leukemia, Myeloid, Acute

NCT04297605 2026-02-09

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

28 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07381829 2026-02-02

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

328 enrolled

Advanced Solid Tumor Cancer

NCT05421897 2026-01-29

RAPID

Phase 1 Not yet recruiting

11 enrolled

CNS

Neoplasms, Neuroblastoma

NCT07335380 2026-01-29

Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma

30 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06997094 2026-01-26

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

24 enrolled

Human Papillomavirus-Negative Neck Squamous Cell Carcinoma

NCT07319364 2026-01-06

A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects

90 enrolled

Gastrointestinal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT07297173 2025-12-22

Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia

Other hematologic neoplasm

5 enrolled

Leukemia

NCT05723107 2025-11-28

EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)

15 enrolled

Pancreatic Neoplasms

NCT04185883 2025-10-22

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Other solid neoplasmSarcoma

610 enrolled

Advanced Solid Tumors

NCT03426891 2025-10-06

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

21 enrolled 12 charts

CNS

Brain Neoplasms, Glioblastoma

NCT06896422 2025-08-07

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04046133 2025-08-05

CORINTH

52 enrolled

Anus Neoplasms

NCT05704985 2025-05-29

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

39 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Pancreatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

NCT04062721 2025-04-06

LICoRN-01

Phase 1 Not yet recruiting

12 enrolled

Colorectal Neoplasms

NCT06344156 2025-02-28

Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer

43 enrolled

Pancreatic Neoplasms

NCT04091867 2025-02-24

sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC

3 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT01957735 2025-02-19

BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

97 enrolled

CNSLymphoid

Brain Neoplasms, Lymphoma, Neoplasm Metastasis, Neoplasms

NCT02671890 2025-01-07

Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer

16 enrolled

Pancreatic Neoplasms

NCT05979818 2024-11-19

BRIO

6 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03873883 2024-09-19

IO-001

119 enrolled

Tumor-Agnostic

Neoplasms

NCT05684731 2024-08-13

K19017-004

30 enrolled

Gynecologic

Ovarian Neoplasms

NCT03539406 2024-08-09

INTRO

11 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06468098 2024-07-18

A Study of IBI363 in Subjects With Advanced Malignancies

556 enrolled

Advanced Malignancies

NCT06418113 2024-05-16

GLINERA

12 enrolled

CNS

Brain Neoplasms, Glioblastoma

NCT03874897 2024-04-30

Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.

134 enrolled

Phase 1 Not yet recruiting

Advanced Solid Tumor

NCT06346808 2024-04-04

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

20 enrolled

Pancreatic Neoplasms

NCT03329950 2024-03-28

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

132 enrolled

Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Cholangiocarcinoma, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Hyper-IgM Immunodeficiency Syndrome

NCT06206902 2024-02-23

F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma

Phase 1 Unknown

55 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT04894825 2023-11-27

Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China

Phase 1 Unknown

152 enrolled

Advanced Unresectable Solid Tumors

NCT04836871 2023-07-13

Double Filtration Plasmapheresis Combined With Chemotherapy

Phase 1 Unknown

20 enrolled

Plasma cell

Multiple Myeloma

NCT04572100 2023-07-07

Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer

50 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03236857 2023-05-22

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

CNSLymphoidOther hematologic neoplasm

143 enrolled

Lymphoma, Non-Hodgkin, Neoplasms, Neuroblastoma, Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05388279 2023-03-23

A Clinical Study to Evaluate the Safety and Tolerability of JS012 in Advanced or Metastatic Solid Tumors

3 enrolled